Malignant Peritoneal Neoplasm Completed Phase 1 Trials for Oxaliplatin (DB00526)

Also known as: Peritoneal Cancer / Malignant neoplasm of peritoneum, unspecified / Malignant peritoneal neoplasm NOS

IndicationStatusPhase
DBCOND0073968 (Malignant Peritoneal Neoplasm)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00491855Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal CarcinomatosisTreatment